Microbio Co., Ltd. (4128.TWO)
Taipei Exchange · TWD · Consumer Defensive · Packaged Foods
NT$14.60 (+0.00%) as of
Key statistics
- Market cap
- 8.59B
- P/E (TTM)
- 16.59
- EPS (TTM)
- 0.88
- Dividend yield
- 0.00%
- 52-week range
- 13.60 – 22.80
- Beta
- 0.49
- Revenue (TTM)
- 1.97B
- Profit margin
- 26.62%
- Volume
- 110.55k
About Microbio Co., Ltd.
Microbio Co., Ltd. researches, develops, manufactures, and trades in biotech drugs and health foods in Taiwan. It provides MS-20 for fatigue and appetite loss associated with cancer chemotherapy; and Herbiron, which reveals symptoms of iron deficiency anemia in women before menopause and relieved dysmenorrhea. The company is also involved in the sale of organic food and beverages; provision of technology development, transfer, and consulting services; and publishing of magazine, as well as offers business consulting services. Microbio Co., Ltd. was incorporated in 2000 and is based in Taipei, Taiwan.
- Sector
- Consumer Defensive
- Industry
- Packaged Foods
- Headquarters
- Taipei, Taiwan
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.